Two members of Congress investigating drug-price increases asked Valeant Pharmaceuticals for information that would help explain why it raised the prices earlier this year for two commonly used heart drugs.
from WSJ.com: US Business http://ift.tt/1IS9Vf5
via IFTTT
No comments:
Post a Comment